๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Non-metastatic Prostate Cancer

Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R) NCT07210086Phase 21 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: ADT, ARSI, No ADT/ARSI -decline An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea NCT06334120n/a1 site๐Ÿ“ Multiple Locations Bayer ยท Tests: Darolutamide (Nubeqa, BAY1841788) An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial NCT06813898EARLY Phase 11 site๐Ÿ“ Chicago Northwestern University ยท Tests: Computed Tomography, Electronic Health Record Review, Flotufolastat F-18 Gallium, Positron Emission Tomography A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-1607, Paclitaxel EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ยฑ Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: EBNK-001 + IL-15 + Pembrolizumab Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. NCT07483658NA4 sites๐Ÿ“ Gatineau๐Ÿ“ Montreal๐Ÿ“ Montreal CHU de Quebec-Universite Laval ยท Tests: Standard Fractionation Post-Operative Salvage Radiotherapy (25 fractions), Hypofractionated Post-Operative Salvage Radiโ€ฆ Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA โ‰ฅ 0.2 ng/mL (EvoPAR-PR05) NCT07711002Phase 3210 sites๐Ÿ“ Hot Springs๐Ÿ“ Springdale๐Ÿ“ Beverly Hills AstraZeneca ยท Tests: Saruparib, Placebo, Enzalutamide, Darolutamide, Abiraterone A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069Phase 139 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Eli Lilly and Company ยท Tests: LY4052031, Pembrolizumab A Study of DB-1310 in Advanced/Metastatic Solid Tumors NCT05785741Phase 1, Phase 224 sites๐Ÿ“ Sacramento๐Ÿ“ Santa Monica๐Ÿ“ Coral Gables DualityBio Inc. ยท Tests: DB-1310, Trastuzumab, Osimertinib, capecitabine A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors NCT07887971Phase 11 site๐Ÿ“ Miami Aktis Oncology, Inc. ยท Tests: [225Ac]Ac-AKY-2519 (therapeutic), [64Cu]Cu-AKY-2519 (imaging) Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer NCT06468332n/a1 site๐Ÿ“ Novara Azienda Ospedaliero Universitaria Maggiore della Carita Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial. NCT07333066Phase 356 sites๐Ÿ“ Bayonne๐Ÿ“ Bordeaux๐Ÿ“ Brest Alianza multidisciplinar para la investigaciรณn de los tumorโ€ฆ ยท Tests: Apalutamide (Erleadaโ„ข) 60 mg or 240 mg tablets, Docetaxel Pluvicto Real-world Investigation in Survival in Metastatic CRPC NCT07697989n/a1 site๐Ÿ“ East Hanover Novartis Pharmaceuticals 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors NCT07189871Phase 1, Phase 25 sites๐Ÿ“ Dothan๐Ÿ“ Grand Rapids๐Ÿ“ Omaha Radiopharm Theranostics, Ltd ยท Tests: 177Lu-BetaBart, BetaBart + unlabeled BetaBart A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success MacroGenics ยท Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion, Pembrollizumab, vobramitamab tavatecan A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) NCT05348876Phase 425 sites๐Ÿ“ Vijayawada๐Ÿ“ Visakhapatnam๐Ÿ“ Nadiฤd Bayer ยท Tests: Darolutamide (Nubeqa, BAY1841788) First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine NCT05104515Phase 14 sites๐Ÿ“ London๐Ÿ“ London๐Ÿ“ Manchester Oxford Vacmedix UK Ltd. ยท Tests: OVM-200 This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors NCT06451497Phase 13 sites๐Ÿ“ Boston๐Ÿ“ Austin, TX 78758๐Ÿ“ San Antonio Zumutor Biologics Inc. ยท Tests: ZM008 Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN) NCT07290270n/a1 site๐Ÿ“ Shanghai Novartis Pharmaceuticals Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro) NCT07365423Phase 211 sites๐Ÿ“ Baden๐Ÿ“ Basel๐Ÿ“ Bellinzona Swiss Cancer Institute ยท Tests: Terbinafine A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors NCT07181473Phase 17 sites๐Ÿ“ Orlando๐Ÿ“ Nashville๐Ÿ“ Houston Phrontline Biopharma ยท Tests: TJ101 Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL NCT05588128n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: 18F-DCFpyL A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites๐Ÿ“ Denver๐Ÿ“ Sarasota๐Ÿ“ Detroit IDEAYA Biosciences ยท Tests: IDE034 A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776Phase 1, Phase 280 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Chicago Novartis Pharmaceuticals ยท Tests: Tulmimetostat, Enzalutamide Radiation Therapy Approaches for People With Prostate Cancer NCT07751159Phase 27 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Standard of Care HDR Brachytherapy, SBRT Radiotherapy After Prostatectomy for Node Positive Prostate Cancer NCT07477626Phase 313 sites๐Ÿ“ Dongguan๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Androgen Deprivation Therapy (ADT), radiotherapy A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas NCT06999187Phase 110 sites๐Ÿ“ Denver๐Ÿ“ Orlando๐Ÿ“ Sarasota Dren Bio ยท Tests: DR-0202 Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors NCT05983432Phase 137 sites๐Ÿ“ Beverly Hills๐Ÿ“ Duarte๐Ÿ“ Orange SystImmune Inc. ยท Tests: BL-B01D1 IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy NCT07686380Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: N-803, ETBX-71 Vaccine, 18F-DCFPyL SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Scottsdale Massive Bio, Inc. ยท Tests: Clinical Trial Matching
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy